Swiss National Bank lessened its stake in shares of Perrigo (NYSE:PRGO) by 14.5% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 406,662 shares of the company’s stock after selling 68,800 shares during the quarter. Swiss National Bank owned approximately 0.29% of Perrigo worth $33,891,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors also recently bought and sold shares of the stock. Crossmark Global Holdings Inc. boosted its stake in Perrigo by 8.3% in the 4th quarter. Crossmark Global Holdings Inc. now owns 7,741 shares of the company’s stock worth $675,000 after buying an additional 595 shares during the last quarter. New Mexico Educational Retirement Board boosted its stake in Perrigo by 5.0% in the 4th quarter. New Mexico Educational Retirement Board now owns 12,700 shares of the company’s stock worth $1,107,000 after buying an additional 600 shares during the last quarter. Norinchukin Bank The boosted its stake in Perrigo by 6.1% in the 4th quarter. Norinchukin Bank The now owns 10,472 shares of the company’s stock worth $913,000 after buying an additional 601 shares during the last quarter. Sentry Investment Management LLC boosted its stake in Perrigo by 9.0% in the 1st quarter. Sentry Investment Management LLC now owns 9,140 shares of the company’s stock worth $762,000 after buying an additional 751 shares during the last quarter. Finally, Public Employees Retirement Association of Colorado boosted its stake in Perrigo by 3.1% in the 4th quarter. Public Employees Retirement Association of Colorado now owns 25,067 shares of the company’s stock worth $2,185,000 after buying an additional 765 shares during the last quarter. Hedge funds and other institutional investors own 79.52% of the company’s stock.
Get Perrigo alerts:
PRGO has been the topic of a number of research analyst reports. Cantor Fitzgerald set a $107.00 price target on Perrigo and gave the stock a “buy” rating in a research note on Friday, January 19th. Berenberg Bank initiated coverage on Perrigo in a research note on Thursday, February 1st. They issued a “buy” rating and a $117.00 price target on the stock. Oppenheimer reissued a “buy” rating and issued a $98.00 price target on shares of Perrigo in a research note on Tuesday, February 27th. Canaccord Genuity set a $105.00 price target on Perrigo and gave the stock a “buy” rating in a research note on Tuesday, February 27th. Finally, JPMorgan Chase reissued a “neutral” rating and issued a $83.00 price target (up from $82.00) on shares of Perrigo in a research note on Monday, March 5th. Two analysts have rated the stock with a sell rating, eight have given a hold rating and nine have given a buy rating to the stock. The company has an average rating of “Hold” and a consensus target price of $93.06.
Shares of NYSE:PRGO opened at $75.86 on Friday. The stock has a market cap of $10.48 billion, a P/E ratio of 14.69, a P/E/G ratio of 1.78 and a beta of 0.77. The company has a current ratio of 2.08, a quick ratio of 1.48 and a debt-to-equity ratio of 0.53. Perrigo has a one year low of $75.66 and a one year high of $76.20.
Perrigo (NYSE:PRGO) last announced its earnings results on Tuesday, May 8th. The company reported $1.26 EPS for the quarter, beating the consensus estimate of $1.14 by $0.12. The business had revenue of $1.22 billion for the quarter, compared to the consensus estimate of $1.21 billion. Perrigo had a return on equity of 11.93% and a net margin of 2.59%. The company’s revenue was up 1.9% on a year-over-year basis. During the same period last year, the business posted $1.05 EPS. equities analysts forecast that Perrigo will post 5.25 earnings per share for the current year.
The business also recently announced a quarterly dividend, which will be paid on Tuesday, June 19th. Investors of record on Friday, June 1st will be issued a dividend of $0.19 per share. The ex-dividend date of this dividend is Thursday, May 31st. This represents a $0.76 annualized dividend and a dividend yield of 1.00%. Perrigo’s payout ratio is currently 15.42%.
In related news, Director Jeffrey C. Smith bought 250,000 shares of the company’s stock in a transaction that occurred on Tuesday, May 15th. The shares were acquired at an average cost of $75.21 per share, for a total transaction of $18,802,500.00. Following the acquisition, the director now owns 528 shares in the company, valued at approximately $39,710.88. The purchase was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Uwe Roehrhoff bought 7,500 shares of the company’s stock in a transaction that occurred on Monday, March 5th. The shares were bought at an average price of $81.85 per share, for a total transaction of $613,875.00. Following the completion of the acquisition, the chief executive officer now owns 4,900 shares in the company, valued at approximately $401,065. The disclosure for this purchase can be found here. Over the last quarter, insiders have purchased 307,500 shares of company stock worth $23,210,875. Company insiders own 6.90% of the company’s stock.
Perrigo Company plc, a healthcare company, manufactures and supplies over-the-counter (OTC) healthcare products, infant formulas, branded OTC products, and generic pharmaceutical products worldwide. The company operates through Consumer Healthcare Americas, Consumer Healthcare International, and Prescription Pharmaceuticals segments.